Advertisement Genoptix and Biogen Idec to collaborate - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Genoptix and Biogen Idec to collaborate

Personalized medicine services laboratory Genoptix has announced that it will provide expertise in flow cytometry testing to Biogen Idec and collaborate with the company in assay development to support upcoming clinical trials.

Genoptix is known for its focus on providing high-quality and personalized clinical esoteric services to hematologists/oncologists, which aid in the evaluation and management of hematomalignancies.

In addition, Genoptix supports clinical trials of companies with potential therapeutics in the area of hematomalignancy.

“This opportunity allows both Genoptix and Biogen Idec to work to their respective strengths and improve the development of new drugs,” said Dr Tina Nova, Genoptix president and CEO. “We feel strongly that our organization is well poised to provide the type of flexibility, innovative thinking and collaborative approach that will help create value for both companies and benefit physicians and patients.”